| <strong>Bisphosphonates (BP)</strong> <br> Alendronate (oral) <br> Risedronate (oral) <br> Ibandronate (oral/ IV) <br> Zoledronic acid (IV) <br> <strong>PTH &amp; PTHrP Agonists</strong> <br> Teriparatide (TER) <br> Abaloparatide (ABL) <br> <strong>Anti-RANKL</strong> <br> Denosumab (DEN) <br> <strong>Selective Estrogen Receptor Modulator</strong> <br> Raloxifene (RAL) <br> <strong>Anti-sclerostin</strong> <br> Romosozumab (ROM) | We strongly recommend OP treatment for those at moderate, high